Phio Pharmaceuticals Corp. (PHIO) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)

Phio Pharmaceuticals Corp. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. Phio Pharmaceuticals Corp. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($12.8M and $12.4M). Across the 8 metrics below, Phio Pharmaceuticals Corp. leads on 6 and Quoin Pharmaceuticals, Ltd. Sponsored ADR on 2.

Valuation

Metric PHIO QNRX Biotechnology median
P/E n/m n/m 7.88
P/S 86.27 n/m 11.47
P/B 0.93 4.63 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.09 n/m 0.74
EV/Sales (9.03) n/m 10.73
Earnings yield (127.72%) (391.60%) (28.84%)
Free cash flow yield (104.03%) (15.72%) (23.03%)

Profitability

Metric PHIO QNRX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (113.71%) (575.73%) (57.72%)
Return on assets (100.78%) (178.77%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHIO QNRX Biotechnology median
Revenue growth (TTM) 78.95% — 5.64%
EPS growth (last fiscal year) 84.03% 77.84% —
Revenue growth, 5-year CAGR (21.62%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHIO QNRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.39 1.76 4.73
Net debt to EBITDA 2.28 1.16 0.96

Dividend

Metric PHIO QNRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PHIO QNRX Biotechnology median
Market cap 12.43m 12.82m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack